About CV Sciences
CV Sciences is a publicly listed company based in Las Vegas (United States) founded in 2010 by Michael Mona. Cannabidiol-based pharmaceuticals and consumer products are developed and distributed. CV Sciences has raised $55.05 thousand across 7 funding rounds. The company has 49 employees. CV Sciences has completed 3 acquisitions, including Cultured Foods, Elevated Softgels and Extract Labs. Its chief executive, as recorded, is Joseph Dowling. CV Sciences offers products and services including PlusCBD Oil, Balm, Edibles, Skincare, and Softgels. Its focus areas include Retail, Cannabis Brands and Retailers, Brands and Application Specific. Its legal entity is CV Sciences, Inc. Its competitors include Lucid Green, Curio Wellness and Wana Brands; 2 of its 3 listed competitors have raised funding.
Company details
CV Sciences was founded in 2010 and is headquartered in Las Vegas, United States. Operations focus on the development of cannabidiol-based pharmaceuticals and consumer products within the health and wellness sector. A hemp-derived CBD oil has been produced and made available through online channels, health food stores, and practitioners offices. Leadership includes co-founder Michael Mona and CEO Joseph Dowling.
- Annual Revenue$13.79 M (USD)-12.2as on Dec 31, 2025
- Net Profit-$958 K (USD)59.98as on Dec 31, 2025
- EBITDA-$562 K (USD)69.72as on Dec 31, 2025
- Total Equity Funding$55.05K (USD)
in 7 rounds
- Latest Funding Round$750K (USD), Post-IPO
Mar 2017
- Employee Count49
- Investments & AcquisitionsCultured Foods
& 2 more
Products & Services of CV Sciences
CV Sciences offers a comprehensive portfolio of products and services, including PlusCBD Oil, Balm, Edibles, Skincare, and Softgels.
CBD oil product for supporting overall wellness and health benefits.
Topical balm with CBD for targeted pain and skin relief.
CBD-infused edibles for daily wellness consumption.
CBD-based skincare items for skin health maintenance.
CBD softgels for convenient daily health supplementation.
Apps and channels of CV Sciences
its YouTube channel CV Sciences has 2.58K subscribers and 30 videos.
Videos from CV Sciences
The most watched videos on CV Sciences's YouTube channel, CV Sciences (2.58K subscribers). Click a video to play it here.
More on CV Sciences.
Funding Insights of CV Sciences
CV Sciences has successfully raised a total of $55.05K across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $750 thousand completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $55,050
- Total Rounds 7
- Last Round Post-IPO — $750,000
- First Round $55,050
(Dec 2010)
All 7 funding rounds of CV Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | $750,000 | Post-IPO | – | – | – |
| Jun 2016 | $2M | Post-IPO | – | – | – |
| May 2015 | $510,000 | Debt – Conventional | – | – | – |
| Apr 2014 | $1.14M | Post-IPO | – | – | – |
| Dec 2013 | $2.75M | Post-IPO | – | – | – |
| Jan 2013 | $4.5M | Post-IPO | – | – | – |
| Dec 2010 | $55,050 | Seed | – | – | – |
People of CV Sciences
15 people are tracked at CV Sciences (8 in leadership, 7 in team); the tracked headcount is 49.
| Name | Role | Group |
|---|---|---|
Michael Mona | Co-Founder | Leadership |
Joseph Dowling | CEO | Leadership |
tâo thao | General Manager | Leadership |
Andrew Dorf | Vice President Of Sales And Marketing | Leadership |
Joerg Grasser | Chief Financial Officer | Leadership |
Matthew Bolen | Creative Director | Leadership |
Shannon Thomas | Associate Director of Sales | Leadership |
Austin Whitty | Associate Director of Ecommerce | Leadership |
Daniel Degner | FP&A Manager | Team |
Aleksandar Sakota | Inside Sales Manager | Team |
Tom Ball | National Sales Manager | Team |
Nicholas Gaeta | Lead Account Executive | Team |
Jeanina Rada | Account Specialist | Team |
Sophia U. | Inside Sales Rep | Team |
Michelle Morganti | Retail Operations Manager | Team |
Complete people profiles for CV Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of CV Sciences
CV Sciences is a publicly listed company on the OTC with ticker symbol CVSI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Apr 2013
- Listed onNASDAQ: CVSI
- Listed entityCV Sciences, Inc.
- Exchange sectorHealth technology
- ISINUS1266541028
- Share price$0.01 (+6.67% on the day) · 2026-10-13
- Market capitalisation$3.3M
- EPS (diluted, trailing year)$-0.01
- Volume (last session)74,502
Financials of CV Sciences
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $13.8M | -$958,000 | -$562,000 |
| 2024 | $15.7M | -$2.4M | -$1.9M |
| 2023 | $16.0M | $3.1M | -$2.2M |
| 2022 | $16.2M | -$8.2M | -$4.5M |
| 2021 | $20.1M | -$15.6M | -$11.0M |
Detailed financial statements for CV Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CV Sciences
CV Sciences has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cultured Foods, Elevated Softgels and Extract Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CBD-infused products are manufactured and supplied by Extract Labs. | extractlabs.com | Boulder, United States | 2016 | Nov 2024 | $399,998 | |
Private label cannabis research and production services are offered. | elevatedsoftgels.com | Grand Junction, United States | 2019 | May 2024 | $800,000 | |
Provider of all-natural, vegan, and gluten-free products with probiotics | culturedfoods.eu | Pulawy, Poland | 2017 | Dec 2023 | •••• |
Complete acquisition details for CV Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CV Sciences
7 dated milestones of CV Sciences across 14 years, from founding to its latest funding, stage changes and deals.
- Founded CV Sciences is founded.
- Funding First funding round of $55K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $750K.
- Acquisition Acquires Cultured Foods.
- Acquisition Acquires Elevated Softgels.
- Acquisition Acquires Extract Labs.
Competitors of CV Sciences
CV Sciences has 3 listed competitors in our database, 2 of them funded. They include Lucid Green, Curio Wellness and Wana Brands.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lucidgreen.io | 2018 | New York, United States | $17.14M | Cannabis-based product information is provided for consumer education. | ||
| curiowellness.com | 2014 | Baltimore, United States | $25.58M | 139 | Medical cannabis products for sleep disorders are provided. | |
| wanabrands.com | 2010 | Boulder, United States | Cannabis-infused jellies in various flavors are developed for consumers. |
Detailed competitors of CV Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CV Sciences
The website of CV Sciences (cvsciences.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▼ 7.1% vs previous month
Websites whose visitors overlap most with CV Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pluscbdoil.com | 100% | 38.6K | #607,219 | View details |
Top companies in Cannabis Industry & Retail
3 companies that operate in the same segment as CV Sciences (Cannabis Industry & Retail) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Comprehensive management and consulting services for marijuana operations are provided. | 2010 | Culver City, California, United States | USD 202.64 M | USD 140.81 M | ||
Cannabis-related health and wellbeing products are provided nationally. | 2002 | Chicago, Illinois, United States | USD 824.73 M | 4,600 | ||
Cannabis plants and products services are provided by AWH. | 2014 | Cambridge, Massachusetts, United States | USD 134.83 M | USD 500.58 M | 2,300 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cv Sciences
Complete news archive for CV Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CV Sciences
CV Sciences was founded in 2010.
CV Sciences is headquartered in Las Vegas, United States. It is registered at Las Vegas, Nevada, United States.
Joseph Dowling is the CEO of CV Sciences, as recorded in our data.
CV Sciences is a funded company, having raised a total of $55.05K across 7 funding rounds to date. The company's 1st funding round was a Seed of $55.05K, raised on Dec 2010.
CV Sciences has 49 employees.
Annual revenue of CV Sciences is $13.79M as on Dec 31, 2025.
CV Sciences was founded in 2010 and is headquartered in Las Vegas, United States. Operations focus on the development of cannabidiol-based pharmaceuticals and consumer products within the health and wellness sector. A hemp-derived CBD oil has been produced and made available through online channels, health food stores, and practitioners offices. Leadership includes co-founder Michael Mona and CEO Joseph Dowling.
CV Sciences's top competitors include Curio Wellness, Lucid Green and Wana Brands.
CV Sciences offers PlusCBD Oil, Balm, Edibles, Skincare, and Softgels.
Yes, CV Sciences is publicly traded on OTC under the ticker symbol CVSI.
CV Sciences has made 3 acquisitions, including Cultured Foods, Elevated Softgels, and Extract Labs.
CV Sciences operates through Cv Sciences, Inc..